title: Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.
authors.affiliation: Sansum Medical Research Institute, Santa Barbara, California 93105, USA.
authors.forename: L
authors.initials: L
authors.lastname: Jovanovic
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology*; D003930:Diabetic Retinopathy / Q000453:epidemiology* / Q000209:etiology*; D006728:Hormones / Q000502:physiology*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives*; D061268:Insulin Lispro; D012307:Risk Factors
chemical_list: D006728:Hormones; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro